Galera Therapeutics, Inc. (GRTX)

Pharmaceutical Preparations · Healthcare · $966M

overvalued
Intrinsic Value (Consensus)
$9.51
Current Price
$12.80
Margin of Safety
-25.7%
25.7% Above Intrinsic Value
Value: $10
Price: $13

Valuation Model Estimates

Current Price: $12.80
DCF (Discounted Cash Flow)
Not applicable
Graham Number
$0.87
Earnings Power Value
$6.21
Relative Value (P/E)
$12.80
Dividend Discount Model
Not applicable
Consensus Value
$9.51

Model Assumptions

Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$0.64
EPS (Forward)
$0.67
Book Value
$0.05
P/E Ratio
20.0
Forward P/E
19.0
PEG Ratio
ROE
3750.6%
Debt/Equity
Revenue Growth
N/A
Earnings Growth
5.0%
Dividend Yield
N/A
Beta
1.00

Data last updated: 2026-06-12

Source: Yahoo Finance